Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Blobel Friedhelm
Relationship:   President, CEO, Direct...
City:   San Mateo
State:   CA
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   0    

Indirect Shares

   0      
Direct Value   $0    

Indirect Value

   $0      
Total Shares   0      
Total Value   $0      


                                          Charting Not Avaliable
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Sciclone Pharmaceuticals Inc SCLN President, CEO, Direct... 2017-10-13 0 2007-11-20 0    Premium*  
* Premium Members only  

Records found :    173         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 6 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-03-06 4 AS $10.30 $31,787 D/D (3,087) 87,526 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-03-06 4 OE $3.55 $10,959 D/D 3,087 90,613 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-03-15 4 OE $0.00 $0 D/D 5,000 92,526 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-03-21 4 AS $9.51 $288,496 D/D (30,338) 92,526 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-03-21 4 OE $3.55 $107,700 D/D 30,338 122,864 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-03-22 4 AS $9.33 $90,126 D/D (9,662) 92,526 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-03-22 4 OE $3.55 $34,300 D/D 9,662 102,188 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-04-20 4 AS $9.60 $112,111 D/D (11,678) 92,526 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-04-20 4 OE $3.55 $41,457 D/D 11,678 104,204 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-04-21 4 OE $3.55 $57,375 D/D 16,162 108,688 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-04-21 4 AS $9.47 $153,130 D/D (16,162) 92,526 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-04-24 4 AS $9.64 $117,228 D/D (12,160) 92,526 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-04-24 4 OE $3.55 $43,168 D/D 12,160 104,686 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-04-26 4 AS $10.00 $14,000 D/D (1,400) 92,526 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-04-26 4 OE $3.55 $4,970 D/D 1,400 93,926 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-04-27 4 OE $3.55 $9,940 D/D 2,800 95,326 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-04-27 4 AS $10.01 $28,023 D/D (2,800) 92,526 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-04-28 4 AS $10.00 $2,000 D/D (200) 92,526 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-04-28 4 OE $3.55 $710 D/D 200 92,726 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-05-01 4 AS $10.00 $1,640 D/D (164) 92,526 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-05-01 4 OE $3.55 $582 D/D 164 92,690 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-05-11 4 AS $10.00 $182,315 D/D (18,226) 92,526 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-05-11 4 OE $3.55 $64,702 D/D 18,226 110,752 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-05-22 4 AS $9.44 $175,026 D/D (18,536) 92,526 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-05-22 4 OE $3.55 $65,803 D/D 18,536 111,062 0 -
  173  Records found
  1   2   3   4   5   6  7      
  Page 6 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us